Alogliptin plus metformin initial combination therapy was well tolerated yet more efficacious in controlling glycemia in drug-naïve T2DM patients than either as monotherapy (Diabetes, Obesity and Metabolism)
Diabetes News Service
Alogliptin plus metformin initial combination therapy was well tolerated yet more efficacious in controlling glycemia in drug-naïve T2DM patients than either as monotherapy (Diabetes, Obesity and Metabolism)
For iPhone and iPad | For Android devices
For information about sponsorship and advertising please contact our editor-in-chief Jim Young jim@glycosmedia.com
Website by Wired up Wales